7Baggers
 FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital  MarketBeat Fri, 14 Nov 2025 13:50:25 GMT
 Analysts Set Expectations for OLMA FY2025 Earnings  MarketBeat Fri, 14 Nov 2025 13:48:17 GMT
 Olema Oncology (OLMA) Advances Cancer Treatment Trials  GuruFocus Mon, 10 Nov 2025 12:36:12 GMT
 Olema Pharma Q3 net loss widens  TradingView Mon, 10 Nov 2025 12:15:54 GMT
 Olema Oncology reports Q3 EPS (49c), consensus (45c)  TipRanks Mon, 10 Nov 2025 08:00:00 GMT
 olema pharmaceuticals engages investors at key conferences  Traders Union Tue, 04 Nov 2025 17:15:26 GMT
 Olema Oncology to Participate in Upcoming Investor Conferences  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
 td cowen maintains olema pharmaceuticals(olma.us) with buy rating  富途牛牛 Sun, 02 Nov 2025 07:00:00 GMT
 Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap Up - Here's Why  MarketBeat Sat, 01 Nov 2025 07:00:00 GMT
 can olema pharmaceuticals deliver on lofty growth projections?  AD HOC NEWS Fri, 31 Oct 2025 10:14:04 GMT
 Olema Oncology to Present Trial-in-Progress Poster for  GlobeNewswire Thu, 30 Oct 2025 07:00:00 GMT
 olema pharmaceuticals welcomes new team to advance cancer therapies  Traders Union Wed, 29 Oct 2025 21:00:10 GMT

Olema Pharmaceuticals, Inc
(NASDAQ:OLMA) 

OLMA stock logo

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clini...

Founded: 2006
CEO: Sean Bohen  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends